Moderna Inc (WBO:MRNA)
€ 38.03 -0.48 (-1.25%) Market Cap: 14.61 Bil Enterprise Value: 9.32 Bil PE Ratio: 0 PB Ratio: 1.30 GF Score: 53/100

Moderna Inc at SVB Leerink Global Healthcare Conference (Virtual) Transcript

Feb 25, 2021 / 06:00PM GMT
Mani Foroohar
SVB Leerink LLC, Research Division - MD of Genetic Medicines & Senior Research Analyst

Hello. It's Mani Foroohar, a senior analyst focused on genetic medicines here at SVB Leerink. And I'm very fortunate on the heels of this morning's earnings call and updated announcements to have Tal Zaks joining us from Moderna. How are you doing this morning, Tal?

Tal Zaks
Moderna, Inc. - Chief Medical Officer

Very well, Mani. Thanks for having me.

Mani Foroohar
SVB Leerink LLC, Research Division - MD of Genetic Medicines & Senior Research Analyst

Obviously, it's been an eventful year, eventful morning, including your transition to eventually another role in the future. Congratulations on a remarkable run over the course of last year, especially. In case people have not noticed, it has been eventful for the vaccine space and Moderna specifically. But before we dive straight into Q&A as I'm sure a lot of investors will have questions, as a reminder, for those in the audience, if you want to send a

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot